Immediate Impact

1 by Nobel laureates 2 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Targeting KRAS in cancer
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
2 intermediate papers

Works of Ioannis Varthalitis being referenced

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study
2018
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
2012

Author Peers

Author Last Decade Papers Cites
Ioannis Varthalitis 571 230 170 182 47 821
Monica Leutner 273 172 106 167 35 915
Vincenzo Montesarchio 360 223 109 153 69 812
Anna Efremidis 586 414 148 176 58 987
J.J. Lafitte 494 472 120 288 37 908
Dae‐Won Lee 406 166 50 274 45 791
Guido Ceci 453 198 109 214 34 749
Rosa Giuliani 507 124 63 159 31 767
C.G. Alexopoulos 404 209 117 146 33 761
Mihaela Mates 557 184 68 94 49 801
Kazuyuki Tsujino 212 448 196 188 57 913

All Works

Loading papers...

Rankless by CCL
2026